Publications

  1. Lohani KR, Nibbe AM, Vierkant RA, Pacheco-Spann LM, Seymour LR, Vachon CM, Sherman ME, Winham SJ, Degnim AC, Hill DA. Understanding benign breast disease and subsequent breast cancer in Hispanic white females; a step closer to evidence-based management. Cancer Epidemiol Biomarkers Prev. 2024 Jun 5 Epub 2024 June 05
    View PubMed
  2. Steadman JA, Hoskin TL, Klassen C, Boughey JC, Degnim AC, Piltin MA, Mrdutt MM, Johnson JE, Hieken TJ. Assessment of the effect of the American Society of Breast Surgery guidelines on contralateral prophylactic mastectomy rates for unilateral breast cancer. Surgery. 2024 Mar; 175 (3):677-686 Epub 2023 Oct 19
    View PubMed
  3. Lohani KR, Hoskin TL, Day CN, Yasir S, Boughey JC, Degnim AC. ASO Visual Abstract: Lobular-Like Features and Outcomes of Mixed Invasive Ductolobular Breast Cancer (MIDLC): Insights from 54,403 Stage I-III MIDLC Patients. Ann Surg Oncol. 2024 Feb; 31 (2):1027-1028
    View PubMed
  4. Sherman ME, Vierkant RA, Winham SJ, Vachon CM, Carter JM, Pacheco-Spann L, Jensen MR, McCauley BM, Hoskin TL, Seymour L, Gehling D, Fischer J, Ghosh K, Radisky DC, Degnim AC. Benign Breast Disease and Breast Cancer Risk in the Percutaneous Biopsy Era. JAMA Surg 2024 Feb 1; 159 (2):193-201
    View PubMed
  5. Lohani KR, Hoskin TL, Day CN, Yasir S, Boughey JC, Degnim AC. ASO Author Reflections: Toward Individualized Management of Heterogenous Mixed Invasive Ductolobular Breast Cancers. Ann Surg Oncol. 2024 Feb; 31 (2):1008-1009 Epub 2023 Nov 12
    View PubMed
  6. Lohani KR, Hoskin TL, Day CN, Yasir S, Boughey JC, Degnim AC. Lobular-Like Features and Outcomes of Mixed Invasive Ductolobular Breast Cancer (MIDLC): Insights from 54,403 Stage I-III MIDLC Patients. Ann Surg Oncol. 2024 Feb; 31 (2):936-946 Epub 2023 Oct 23
    View PubMed
  7. Dilaveri C, Degnim A, Lee C, DeSimone D, Moldoveanu D, Ghosh K. Idiopathic Granulomatous Mastitis. Breast J. 2024; 2024:6693720 Epub 2024 Jan 25
    View PubMed
  8. Khan SA, Mi X, Xu Y, Blanco LZ Jr, Akasha AM, Pilewskie M, Degnim AC, AlHilli Z, Amin AL, Hwang ES, Guenther JM, Kocherginsky M, Benante K, Zhang S, Helland T, Hustad SS, Gursel DB, Mellgren G, Dimond E, Perloff M, Heckman-Stoddard BM, Lee O. Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in Women With Ductal Carcinoma In Situ: A Randomized Clinical Trial. JAMA Surg 2023 Dec 1; 158 (12):1265-1273
    View PubMed
  9. Sarcon AK, Zhang W, Degnim AC, Johnson RL, Harmsen WS, Glasgow AE, Jakub JW. The Benefits of Local Anesthesia Used in Mastectomy Without Reconstruction. Am Surg. 2023 Nov; 89 (11):4271-4280 Epub 2022 June 03
    View PubMed
  10. Stafford AP, Hoskin TL, Hieken TJ, Sanders S, Pruthi S, Boughey J, Degnim A. Lessons learned from the COVID-19 pandemic: Using telemedicine for pre-operative surgical evaluation in breast disease. J Telemed Telecare. 2023 Aug 24; 1357633X231194377 [Epub ahead of print]
    View PubMed
  11. Degnim AC, Siontis BL, Ahmed SK, Hoskin TL, Hieken TJ, Jakub JW, Baum CL, Day C, Schrup SE, Smith L, Carter JM, Sae-Kho TM, Sae Kho TM, Glazebrook KN, Vijayasekaran A, Okuno SH, Petersen IA. Trimodality Therapy Improves Disease Control in Radiation-Associated Angiosarcoma of the Breast. Clin Cancer Res. 2023 Aug 1; 29 (15):2885-2893
    View PubMed
  12. Mohan AT, MacArthur TA, Murphy B, Song AJ, Saifuddin H, Degnim A, Harmsen WS, Martinez-Jorge J, Jakub JW, Vijayasekaran A. Patient Experience and Clinical Outcomes after Same-day Outpatient Mastectomy and Immediate Breast Reconstruction Protocol during the Global Pandemic. Plast Reconstr Surg Glob Open. 2023 Jul; 11 (7):e5183 Epub 2023 July 24
    View PubMed
  13. Kim H, Hieken TJ, Abraha F, Jakub JW, Corbin KS, Furutani KM, Boughey JC, Stish BJ, Deufel CL, Degnim AC, Shumway DA, Ahmed SK, Piltin MA, Sandhu NP, Conners AL, Ruddy KJ, Mutter RW, Park SS. Long-term outcomes of intraoperatively-placed applicator brachytherapy for rapid completion of breast conserving treatment: An analysis of a prospective registry data. Clin Transl Radiat Oncol. 2023 Jul; 41:100639 Epub 2023 May 09
    View PubMed
  14. Sherman ME, Vierkant RA, Masters M, Radisky DC, Winham SJ, Degnim AC, Vachon CM, Patel AV, Teras LR. Benign Breast Disease, NSAIDs, and Postmenopausal Breast Cancer Risk in the CPS-II Cohort. Cancer Prev Res (Phila). 2023 Mar 1; 16 (3):175-184
    View PubMed
  15. Ogony J, Hoskin TL, Stallings-Mann M, Winham S, Brahmbhatt R, Arshad MA, Kannan N, Pena A, Allers T, Brown A, Sherman ME, Visscher DW, Knutson KL, Radisky DC, Degnim AC. Immune cells are increased in normal breast tissues of BRCA1/2 mutation carriers. Breast Cancer Res Treat. 2023 Jan; 197 (2):277-285 Epub 2022 Nov 16
    View PubMed
  16. Robbins T, Hoskin TL, Day CN, Mrdutt MM, Hieken TJ, Jakub JW, Glazebrook K, Boughey JC, Degnim AC. ASO Visual Abstract: Node Positivity Among Sonographically Suspicious but FNA-Negative Axillary Nodes. Ann Surg Oncol. 2022 Dec; 29 (Suppl 3):622-623
    View PubMed
  17. Robbins T, Hoskin TL, Day CN, Mrdutt MM, Hieken TJ, Jakub JW, Glazebrook K, Boughey JC, Degnim AC. Node Positivity Among Sonographically Suspicious but FNA-Negative Axillary Nodes. Ann Surg Oncol. 2022 Oct; 29 (10):6276-6287 Epub 2022 July 19
    View PubMed
  18. Gonzalez TV, Sae-Kho TM, Robinson SI, Hieken TJ, Folpe AL, Broski SM, Degnim AC, Glazebrook KN. Radiation-associated angiosarcoma of the breast with initial presentation as non-mass enhancement on MRI. Radiol Case Rep. 2022 Oct; 17 (10):3624-3629 Epub 2022 July 29
    View PubMed
  19. Liu Y, Bhagwate A, Winham SJ, Stephens MT, Harker BW, McDonough SJ, Stallings-Mann ML, Heinzen EP, Vierkant RA, Hoskin TL, Frost MH, Carter JM, Pfrender ME, Littlepage L, Radisky DC, Cunningham JM, Degnim AC, Wang C. Quality control recommendations for RNASeq using FFPE samples based on pre-sequencing lab metrics and post-sequencing bioinformatics metrics. BMC Med Genomics. 2022 Sep 16; 15 (1):195 Epub 2022 Sept 16
    View PubMed
  20. Ogony J, de Bel T, Radisky DC, Kachergus J, Thompson EA, Degnim AC, Ruddy KJ, Hilton T, Stallings-Mann M, Vachon C, Hoskin TL, Heckman MG, Vierkant RA, White LJ, Moore RM, Carter J, Jensen M, Pacheco-Spann L, Henry JE, Storniolo AM, Winham SJ, van der Laak J, Sherman ME. Towards defining morphologic parameters of normal parous and nulliparous breast tissues by artificial intelligence. Breast Cancer Res. 2022 Jul 11; 24 (1):45 Epub 2022 July 11
    View PubMed
  21. Sherman ME, de Bel T, Heckman MG, White LJ, Ogony J, Stallings-Mann M, Hilton T, Degnim AC, Vierkant RA, Hoskin T, Jensen MR, Pacheco-Spann L, Henry JE, Storniolo AM, Carter JM, Winham SJ, Radisky DC, van der Laak J. Serum hormone levels and normal breast histology among premenopausal women. Breast Cancer Res Treat. 2022 Jul; 194 (1):149-158 Epub 2022 May 03
    View PubMed
  22. Hieken TJ, Chen J, Chen B, Johnson S, Hoskin TL, Degnim AC, Walther-Antonio MR, Chia N. The breast tissue microbiome, stroma, immune cells and breast cancer. Neoplasia. 2022 May; 27:100786 Epub 2022 Mar 30
    View PubMed
  23. Racz JM, Harless CA, Hoskin TL, Day CN, Nguyen MT, Harris AM, Boughey JC, Hieken TJ, Degnim AC. ASO Visual Abstract: Sexual Well-Being After Nipple-Sparing Mastectomy: Does Preservation of the Nipple Matter? Ann Surg Oncol. 2022 Apr 16 [Epub ahead of print]
    View PubMed
  24. Racz JM, Harless CA, Hoskin TL, Day CN, Nguyen MT, Harris AM, Boughey JC, Hieken TJ, Degnim AC. Sexual Well-Being After Nipple-Sparing Mastectomy: Does Preservation of the Nipple Matter? Ann Surg Oncol. 2022 Apr 6 Epub 2022 Apr 06
    View PubMed
  25. de Bel T, Litjens G, Ogony J, Stallings-Mann M, Carter JM, Hilton T, Radisky DC, Vierkant RA, Broderick B, Hoskin TL, Winham SJ, Frost MH, Visscher DW, Allers T, Degnim AC, Sherman ME, van der Laak JAWM. Automated quantification of levels of breast terminal duct lobular (TDLU) involution using deep learning. NPJ Breast Cancer. 2022 Jan 19; 8 (1):13
    View PubMed
  26. Asaad M, Yonkus JA, Hoskin TL, Hieken TJ, Jakub JW, Boughey JC, Degnim AC. Primary tumor resection in patients with stage IV breast cancer: 10-year experience. Breast J. 2021 Dec; 27 (12):863-871 Epub 2021 Oct 14
    View PubMed
  27. Murphy BM, Hoskin TL, Degnim AC, Boughey JC, Hieken TJ. ASO Visual Abstract: Surgical Management of Axilla Following Neoadjuvant Endocrine Therapy. Ann Surg Oncol 2021 Dec; 28 (Suppl 3):560-561
    View PubMed
  28. Murphy BM, Hoskin TL, Degnim AC, Boughey JC, Hieken TJ. Surgical Management of Axilla Following Neoadjuvant Endocrine Therapy. Ann Surg Oncol. 2021 Dec; 28 (13):8729-8739 Epub 2021 July 17
    View PubMed
  29. Winham SJ, Wang C, Heinzen EP, Bhagwate A, Liu Y, McDonough SJ, Stallings-Mann ML, Frost MH, Vierkant RA, Denison LA, Carter JM, Sherman ME, Radisky DC, Degnim AC, Cunningham JM. Somatic mutations in benign breast disease tissues and association with breast cancer risk. BMC Med Genomics. 2021 Jul 14; 14 (1):185 Epub 2021 July 14
    View PubMed
  30. Jalalirad M, Haddad TC, Salisbury JL, Radisky D, Zhang M, Schroeder M, Tuma A, Leof E, Carter JM, Degnim AC, Boughey JC, Sarkaria J, Yu J, Wang L, Liu MC, Zammataro L, Malatino L, Galanis E, Ingle JN, Goetz MP, D'Assoro AB. Aurora-A kinase oncogenic signaling mediates TGF-beta-induced triple-negative breast cancer plasticity and chemoresistance. Oncogene. 2021 Apr; 40 (14):2509-2523 Epub 2021 Mar 05
    View PubMed
  31. Pride RM, Jimenez RE, Hoskin TL, Degnim AC, Hieken TJ. Upgrade at excisional biopsy after a core needle biopsy diagnosis of classic lobular carcinoma in situ. Surgery. 2021 Mar; 169 (3):644-648 Epub 2020 Aug 26
    View PubMed
  32. Kim JO, Schaid DJ, Vachon CM, Cooke A, Couch FJ, Kim CA, Sinnwell JP, Hasadsri L, Stan DL, Goldenberg B, Neal L, Grenier D, Degnim AC, Thicke LA, Pruthi S. Impact of Personalized Genetic Breast Cancer Risk Estimation With Polygenic Risk Scores on Preventive Endocrine Therapy Intention and Uptake. Cancer Prev Res (Phila). 2021 Feb; 14 (2):175-184 Epub 2020 Oct 23
    View PubMed
  33. Racz JM, Glasgow AE, Keeney GL, Degnim AC, Hieken TJ, Jakub JW, Cheville JC, Habermann EB, Boughey JC. Intraoperative Pathologic Margin Analysis and Re-Excision to Minimize Reoperation for Patients Undergoing Breast-Conserving Surgery. Ann Surg Oncol. 2020 Dec; 27 (13):5303-5311 Epub 2020 July 04
    View PubMed
  34. Sherman ME, Vierkant RA, Kaggal S, Hoskin TL, Frost MH, Denison L, Visscher DW, Carter JM, Winham SJ, Jensen MR, Radisky DC, Vachon CM, Degnim AC. Breast Cancer Risk and Use of Nonsteroidal Anti-inflammatory Agents After a Benign Breast Biopsy. Cancer Prev Res (Phila). 2020 Nov; 13 (11):967-976 Epub 2020 July 27
    View PubMed
  35. Kilbreath SL, Ward LC, Davis GM, Degnim AC, Hackett DA, Skinner TL, Black D. Reduction of breast lymphoedema secondary to breast cancer: a randomised controlled exercise trial. Breast Cancer Res Treat. 2020 Nov; 184 (2):459-467 Epub 2020 Aug 18
    View PubMed
  36. Asaad M, Meaike J, Yonkus J, Hoskin T, Hieken T, Martinez-Jorge J, Tran N, Nguyen MD, Boughey J, Degnim AC. Breast Reconstruction in the Setting of Stage 4 Breast Cancer: Is It Worthwhile? Ann Surg Oncol. 2020 Nov; 27 (12):4730-4739 Epub 2020 Aug 25
    View PubMed
  37. Ward LC, Degnim AC, Dylke ES, Kilbreath SL. Bioimpedance Spectroscopy of the Breast. Lymphat Res Biol. 2020 Oct; 18 (5):448-454 Epub 2020 Feb 17
    View PubMed
  38. Hallbeck MS, Law KE, Lowndes BR, Linden AR, Morrow M, Blocker RC, Cain SM, Degnim AC, Hieken TJ, Jakub JW, Racz JM, Farley DR, Nelson H, Boughey JC. Workload Differentiates Breast Surgical Procedures: NSM Associated with Higher Workload Demand than SSM. Ann Surg Oncol. 2020 May; 27 (5):1318-1326 Epub 2020 Jan 08
    View PubMed
  39. Manrique OJ, Kapoor T, Banuelos J, Jacobson SR, Martinez-Jorge J, Nguyen MT, Tran NV, Harless CA, Degnim AC, Jakub JW. Single-Stage Direct-to-Implant Breast Reconstruction: A Comparison Between Subpectoral Versus Prepectoral Implant Placement. Ann Plast Surg. 2020 Apr; 84 (4):361-365
    View PubMed
  40. Knutson KL, Block MS, Norton N, Erskine CL, Hobday TJ, Dietz AB, Padley D, Gustafson MP, Puglisi-Knutson D, Mangskau TK, Chumsri S, Dueck AC, Karyampudi L, Wilson G, Degnim AC. Rapid Generation of Sustainable HER2-specific T-cell Immunity in Patients with HER2 Breast Cancer using a Degenerate HLA Class II Epitope Vaccine. Clin Cancer Res. 2020 Mar 1; 26 (5):1045-1053 Epub 2019 Nov 22
    View PubMed
  41. Manrique OJ, Huang TC, Martinez-Jorge J, Ciudad P, Forte AJ, Bustos SS, Boughey JC, Jakub JW, Degnim AC, Galan R. Prepectoral Two-Stage Implant-Based Breast Reconstruction with and without Acellular Dermal Matrix: Do We See a Difference? Plast Reconstr Surg. 2020 Feb; 145 (2):263e-272e
    View PubMed
  42. Adhikary S, Hoskin TL, Stallings-Mann ML, Arshad M, Frost MH, Winham SJ, Pena A, Lee DJ, Murphy LM, Rakoff M, Denison LA, Knutson KL, Radisky DC, Visscher DW, Degnim AC. Cytotoxic T cell depletion with increasing epithelial abnormality in women with benign breast disease. Breast Cancer Res Treat. 2020 Feb; 180 (1):55-61 Epub 2020 Jan 13
    View PubMed
  43. Kilinc D, Shahraki N, Degnim AC, Hoskin TL, Horton TM, Sir MS, Pasupathy KS, Gel ES. Simulation modeling as a decision tool for capacity allocation in breast surgery Proceedings - Winter Simulation Conference. 2020; 2020-December:806-17
  44. Banuelos J, Sabbagh MD, Roh SG, Nguyen MT, Lemaine V, Tran NV, Jacobson SR, Boughey JC, Jakub JW, Hieken TJ, Degnim AC, Mandrekar J, Berbari E, Sharaf B. Infections following Immediate Implant-Based Breast Reconstruction: A Case-Control Study over 11 Years. Plast Reconstr Surg. 2019 Dec; 144 (6):1270-1277
    View PubMed
  45. Young WA, Degnim AC, Hoskin TL, Jakub JW, Nguyen MD, Tran NV, Harless CA, Manrique OJ, Boughey JC, Hieken TJ. Outcomes of > 1300 Nipple-Sparing Mastectomies with Immediate Reconstruction: The Impact of Expanding Indications on Complications. Ann Surg Oncol. 2019 Oct; 26 (10):3115-3123 Epub 2019 July 24
    View PubMed
  46. Sada A, Day CN, Hoskin TL, Degnim AC, Habermann EB, Hieken TJ. Mastectomy and immediate breast reconstruction in the elderly: Trends and outcomes. Surgery. 2019 Oct; 166 (4):709-714 Epub 2019 Aug 05
    View PubMed
  47. Bhagwate AV, Liu Y, Winham SJ, McDonough SJ, Stallings-Mann ML, Heinzen EP, Davila JI, Vierkant RA, Hoskin TL, Frost M, Carter JM, Radisky DC, Cunningham JM, Degnim AC, Wang C. Bioinformatics and DNA-extraction strategies to reliably detect genetic variants from FFPE breast tissue samples. BMC Genomics. 2019 Sep 2; 20 (1):689 Epub 2019 Sept 02
    View PubMed
  48. Lee HE, Arshad M, Brahmbhatt RD, Hoskin TL, Winham SJ, Frost MH, Radisky DC, Denison LA, Degnim AC, Visscher DW. Hyaline fibrous involution of breast lobules: a histologic finding associated with germline BRCA mutation. Mod Pathol. 2019 Sep; 32 (9):1263-1270 Epub 2019 Apr 17
    View PubMed
  49. Degnim AC. Breast atypia as a biomarker of risk Current Breast Cancer Reports. 2019 Sep; 11 (3):95-9
  50. Manrique OJ, Charafeddine A, Abu-Ghname A, Banuelos J, Jacobson SR, Martinez-Jorge J, Nguyen MD, Harless C, Tran NV, Sharaf B, Jakub JW, Hieken TJ, Degnim AC, Boughey JC. Two-Staged Implant-Based Breast Reconstruction: A Long-Term Outcome Study in a Young Population. Medicina (Kaunas). 2019 Aug 14; 55 (8)
    View PubMed
  51. Hruska CB, Hunt KN, Conners AL, Geske JR, Brandt KR, Degnim AC, Vachon CM, O'Connor MK, Rhodes DJ. Impact of short-term low-dose tamoxifen on molecular breast imaging background parenchymal uptake: a pilot study. Breast Cancer Res. 2019 Mar 8; 21 (1):38 Epub 2019 Mar 08
    View PubMed
  52. Manrique OJ, Banuelos J, Abu-Ghname A, Nguyen MD, Tran NV, Martinez-Jorge J, Harless C, Sharaf B, Jakub JW, Degnim AC, Boughey JC, Jacobson SR. Surgical Outcomes of Prepectoral Versus Subpectoral Implant-based Breast Reconstruction in Young Women. Plast Reconstr Surg Glob Open. 2019 Mar; 7 (3):e2119 Epub 2019 Mar 13
    View PubMed
  53. Sugrue M, Johnston A, Degnim A, Rubio IT, Van den Tol MP, Djohan R, Valentine M, MacGregor G. Combined patients and medical related cosmetic breast cancer outcomes: A preferred approach to outcomes assessment Advances in Breast Cancer Research. 2019; 8(1):31-44.
  54. Rao R, Ludwig K, Bailey L, Berry TS, Buras R, Degnim A, Fayanju OM, Froman J, Golesorkhi N, Greenburg C, Ma AT, Mautner SK, Krontiras H, Sowden M, Wexelman B, Landercasper J. Select Choices in Benign Breast Disease: An Initiative of the American Society of Breast Surgeons for the American Board of Internal Medicine Choosing Wisely((R)) Campaign. Ann Surg Oncol. 2018 Oct; 25 (10):2795-2800 Epub 2018 July 02
    View PubMed
  55. Nguyen TT, Hoskin TL, Day CN, Degnim AC, Jakub JW, Hieken TJ, Boughey JC. Decreasing Use of Axillary Dissection in Node-Positive Breast Cancer Patients Treated with Neoadjuvant Chemotherapy. Ann Surg Oncol. 2018 Sep; 25 (9):2596-2602 Epub 2018 July 05
    View PubMed
  56. Frank RD, Winham SJ, Vierkant RA, Frost MH, Radisky DC, Ghosh K, Brandt KR, Sherman ME, Visscher DW, Hartmann LC, Degnim AC, Vachon CM. Evaluation of 2 breast cancer risk models in a benign breast disease cohort. Cancer. 2018 Aug; 124 (16):3319-3328 Epub 2018 June 22
    View PubMed
  57. Yasir S, Nassar A, Jimenez RE, Jenkins SM, Hartmann LC, Degnim AC, Frost M, Visscher DW. Cellular fibroepithelial lesions of the breast: A long term follow up study. Ann Diagn Pathol. 2018 Aug; 35:85-91 Epub 2018 Jan 10
    View PubMed
  58. Hieken TJ, Murphy BL, Boughey JC, Degnim AC, Glazebrook KN, Hoskin TL. Influence of Biologic Subtype of Inflammatory Breast Cancer on Response to Neoadjuvant Therapy and Cancer Outcomes. Clin Breast Cancer. 2018 Aug; 18 (4):e501-e506 Epub 2017 Oct 07
    View PubMed
  59. Degnim AC, Winham SJ, Frank RD, Pankratz VS, Dupont WD, Vierkant RA, Frost MH, Hoskin TL, Vachon CM, Ghosh K, Hieken TJ, Carter JM, Denison LA, Broderick B, Hartmann LC, Visscher DW, Radisky DC. Model for Predicting Breast Cancer Risk in Women With Atypical Hyperplasia. J Clin Oncol. 2018 Jun 20; 36 (18):1840-1846 Epub 2018 Apr 20
    View PubMed
  60. Murphy BL, Gonzalez AB, Keeney MG, Chen B, Conners AL, Henrichsen TL, Degnim AC, Harmsen WS, Boughey JC, Hieken TJ, Habermann EB, Jakub JW. Ability of Intraoperative Pathologic Analysis of Ductal Carcinoma In Situ to Guide Selective Use of Sentinel Lymph Node Surgery. Am Surg. 2018 Apr 1; 84 (4):537-542
    View PubMed
  61. Jakub JW, Peled AW, Gray RJ, Greenup RA, Kiluk JV, Sacchini V, McLaughlin SA, Tchou JC, Vierkant RA, Degnim AC, Willey S. Oncologic Safety of Prophylactic Nipple-Sparing Mastectomy in a Population With BRCA Mutations: A Multi-institutional Study. JAMA Surg. 2018 Feb 1; 153 (2):123-129
    View PubMed
  62. Carter JM, Hoskin TL, Pena MA, Brahmbhatt R, Winham SJ, Frost MH, Stallings-Mann M, Radisky DC, Knutson KL, Visscher DW, Degnim AC. Macrophagic "Crown-like Structures" Are Associated with an Increased Risk of Breast Cancer in Benign Breast Disease. Cancer Prev Res (Phila). 2018 Feb; 11 (2):113-119 Epub 2017 Nov 22
    View PubMed
  63. Landercasper J, Fayanju OM, Bailey L, Berry TS, Borgert AJ, Buras R, Chen SL, Degnim AC, Froman J, Gass J, Greenberg C, Mautner SK, Krontiras H, Ramirez LD, Sowden M, Wexelman B, Wilke L, Rao R. Benchmarking the American Society of Breast Surgeon Member Performance for More Than a Million Quality Measure-Patient Encounters. Ann Surg Oncol. 2018 Feb; 25 (2):501-511 Epub 2017 Nov 22
    View PubMed
  64. Kerekes D, Visscher DW, Hoskin TL, Radisky DC, Brahmbhatt RD, Pena A, Frost MH, Arshad M, Stallings-Mann M, Winham SJ, Murphy L, Denison L, Carter JM, Knutson KL, Degnim AC. CD56+ immune cell infiltration and MICA are decreased in breast lobules with fibrocystic changes. Breast Cancer Res Treat. 2018 Feb; 167 (3):649-658 Epub 2017 Nov 01
    View PubMed
  65. Murphy BL, Zalewski NL, Degnim AC, McKeon A, Flanagan EP, Pittock SJ, Habermann EB. Breast cancer-related paraneoplastic neurologic disease. Breast Cancer Res Treat. 2018 Feb; 167 (3):771-778 Epub 2017 Nov 07
    View PubMed
  66. Racz JM, Degnim AC. When Does Atypical Ductal Hyperplasia Require Surgical Excision? Surg Oncol Clin N Am. 2018 Jan; 27 (1):23-32
    View PubMed
  67. Ghosh K, Vierkant RA, Frank RD, Winham S, Visscher DW, Pankratz VS, Scott CG, Brandt K, Sherman ME, Radisky DC, Frost MH, Hartmann LC, Degnim AC, Vachon CM. Association between mammographic breast density and histologic features of benign breast disease. Breast Cancer Res. 2017 Dec 19; 19 (1):134
    View PubMed
  68. Winham SJ, Mehner C, Heinzen EP, Broderick BT, Stallings-Mann M, Nassar A, Vierkant RA, Hoskin TL, Frank RD, Wang C, Denison LA, Vachon CM, Frost MH, Hartmann LC, Aubrey Thompson E, Sherman ME, Visscher DW, Degnim AC, Radisky DC. NanoString-based breast cancer risk prediction for women with sclerosing adenosis. Breast Cancer Res Treat. 2017 Nov; 166 (2):641-650 Epub 2017 Aug 10
    View PubMed
  69. Rudin AV, Hoskin TL, Fahy A, Farrell AM, Nassar A, Ghosh K, Degnim AC. Flat Epithelial Atypia on Core Biopsy and Upgrade to Cancer: a Systematic Review and Meta-Analysis. Ann Surg Oncol. 2017 Nov; 24 (12):3549-3558 Epub 2017 Aug 22
    View PubMed
  70. Stallings-Mann ML, Heinzen EP, Vierkant RA, Winham SJ, Hoskin TL, Denison LA, Nassar A, Hartmann LC, Visscher DW, Frost MH, Sherman ME, Degnim AC, Radisky DC. Postlactational involution biomarkers plasminogen and phospho-STAT3 are linked with active age-related lobular involution. Breast Cancer Res Treat. 2017 Nov; 166 (1):133-143 Epub 2017 July 27
    View PubMed
  71. Opyrchal M, Gil M, Salisbury JL, Goetz MP, Suman V, Degnim A, McCubrey J, Haddad T, Iankov I, Kurokawa CB, Shumacher N, Ingle JN, Galanis E, D'Assoro AB. Molecular targeting of the Aurora-A/SMAD5 oncogenic axis restores chemosensitivity in human breast cancer cells. Oncotarget. 2017 Oct 31; 8 (53):91803-91816 Epub 2017 Sept 01
    View PubMed
  72. Racz JM, Carter JM, Degnim AC. Lobular Neoplasia and Atypical Ductal Hyperplasia on Core Biopsy: Current Surgical Management Recommendations. Ann Surg Oncol. 2017 Oct; 24 (10):2848-2854 Epub 2017 Aug 01
    View PubMed
  73. Racz JM, Carter JM, Degnim AC. Challenging Atypical Breast Lesions Including Flat Epithelial Atypia, Radial Scar, and Intraductal Papilloma. Ann Surg Oncol. 2017 Oct; 24 (10):2842-2847 Epub 2017 Aug 01
    View PubMed
  74. Jakub JW, Murphy BL, Gonzalez AB, Conners AL, Henrichsen TL, Maimone S 4th, Keeney MG, McLaughlin SA, Pockaj BA, Chen B, Musonza T, Harmsen WS, Boughey JC, Hieken TJ, Habermann EB, Shah HN, Degnim AC. A Validated Nomogram to Predict Upstaging of Ductal Carcinoma in Situ to Invasive Disease. Ann Surg Oncol. 2017 Oct; 24 (10):2915-2924 Epub 2017 Aug 01
    View PubMed
  75. Landercasper J, Bailey L, Buras R, Clifford E, Degnim AC, Thanasoulis L, Fayanju OM, Tjoe JA, Rao R. The American Society of Breast Surgeons and Quality Payment Programs: Ranking, Defining, and Benchmarking More Than 1 Million Patient Quality Measure Encounters. Ann Surg Oncol. 2017 Oct; 24 (10):3093-3106 Epub 2017 Aug 01
    View PubMed
  76. Glorioso JM, Gonzalez Juarrero AB, Rodysill BR, Harmsen WS, Habermann EB, Carter JM, Mutter RW, Degnim AC, Jakub JW. Margin Proximity Correlates with Local Recurrence After Mastectomy for Patients Not Receiving Adjuvant Radiotherapy. Ann Surg Oncol. 2017 Oct; 24 (11):3148-3156 Epub 2017 July 05
    View PubMed
  77. Visscher DW, Frank RD, Carter JM, Vierkant RA, Winham SJ, Heinzen EP, Broderick BT, Denison LA, Allers TM, Johnson JL, Frost MH, Hartmann LC, Degnim AC, Radisky DC. Breast Cancer Risk and Progressive Histology in Serial Benign Biopsies. J Natl Cancer Inst. 2017 Oct 01; 109(10).
    View PubMed
  78. Degnim AC, Hoskin TL, Arshad M, Frost MH, Winham SJ, Brahmbhatt RA, Pena A, Carter JM, Stallings-Mann ML, Murphy LM, Miller EE, Denison LA, Vachon CM, Knutson KL, Radisky DC, Visscher DW. Alterations in the Immune Cell Composition in Premalignant Breast Tissue that Precede Breast Cancer Development. Clin Cancer Res. 2017 Jul 15; 23 (14):3945-3952 Epub 2017 Jan 26
    View PubMed
  79. Pena A, Shah SS, Fazzio RT, Hoskin TL, Brahmbhatt RD, Hieken TJ, Jakub JW, Boughey JC, Visscher DW, Degnim AC. Multivariate model to identify women at low risk of cancer upgrade after a core needle biopsy diagnosis of atypical ductal hyperplasia. Breast Cancer Res Treat. 2017 Jul; 164 (2):295-304 Epub 2017 May 04
    View PubMed
  80. Santen RJ, Radisky DC, Degnim A, Frost MH, Vachon CM, Ghosh K, Guestini F, McNamara KM, Sasano H. Aromatase expression in atypical ductal hyperplasia in women. Breast Cancer Res Treat. 2017 Jun; 163 (3):623-629 Epub 2017 Mar 23
    View PubMed
  81. Murphy BL, Hoskin TL, Boughey JC, Degnim AC, Jakub JW, Krajewski AC, Jacobson SR, Hieken TJ. Outcomes and feasibility of nipple-sparing mastectomy for node-positive breast cancer Patients. Am J Surg. 2017 Apr; 213 (4):810-813 Epub 2016 Sept 03
    View PubMed
  82. Vierkant RA, Degnim AC, Radisky DC, Visscher DW, Heinzen EP, Frank RD, Winham SJ, Frost MH, Scott CG, Jensen MR, Ghosh K, Manduca A, Brandt KR, Whaley DH, Hartmann LC, Vachon CM. Mammographic breast density and risk of breast cancer in women with atypical hyperplasia: an observational cohort study from the Mayo Clinic Benign Breast Disease (BBD) cohort. BMC Cancer. 2017 Jan 31; 17 (1):84
    View PubMed
  83. Mullooly M, Yang HP, Falk RT, Nyante SJ, Cora R, Pfeiffer RM, Radisky DC, Visscher DW, Hartmann LC, Carter JM, Degnim AC, Stanczyk FZ, Figueroa JD, Garcia-Closas M, Lissowska J, Troester MA, Hewitt SM, Brinton LA, Sherman ME, Gierach GL. Relationship between crown-like structures and sex-steroid hormones in breast adipose tissue and serum among postmenopausal breast cancer patients. Breast Cancer Res. 2017 Jan 19; 19 (1):8
    View PubMed
  84. Hieken TJ, Mutter RW, Jakub JW, Boughey JC, Degnim AC, Sukov WR, Childs S, Corbin KS, Furutani KM, Whitaker TJ, Park SS. Erratum to: A Novel Treatment Schedule for Rapid Completion of Surgery and Radiation in Early-Stage Breast Cancer. Ann Surg Oncol. 2016 Dec; 23 (Suppl 5):1059
    View PubMed
  85. Hieken TJ, Mutter RW, Jakub JW, Boughey JC, Degnim AC, Sukov WR, Childs S, Corbin KS, Furutani KM, Whitaker TJ, Park SS. A novel treatment schedule for rapid completion of surgery and radiation in early-stage breast cancer (vol 23, pg 3297, 2016) Annals Of Surgical Oncology. 2016 Dec; 23: S1059.
  86. Stish BJ, Pafundi DH, Hieken TJ, Whitaker TJ, Furutani KM, Jakub JW, Boughey JC, Degnim AC, McLemore LB, Mou B, Mutter RW, Park SS. Feasibility and full-course dosimetry of an intraoperatively placed multichannel brachytherapy catheter for accelerated partial breast irradiation. Brachytherapy. 2016 Nov - Dec; 15 (6):796-803 Epub 2016 Sept 07
    View PubMed
  87. Murphy BL, Hoskin TL, Boughey JC, Degnim AC, Carter JM, Glazebrook KN, Hieken TJ. Contemporary operative management of T4 breast cancer. Surgery. 2016 Oct; 160 (4):1059-1069 Epub 2016 Aug 09
    View PubMed
  88. Throckmorton AD, Rhodes DJ, Hughes KS, Degnim AC, Dickson-Witmer D. Dense Breasts: What Do Our Patients Need to Be Told and Why? Ann Surg Oncol. 2016 Oct; 23 (10):3119-27 Epub 2016 July 11
    View PubMed
  89. Murphy BL, Hoskin TL, Boughey JC, Degnim AC, Glazebrook KN, Hieken TJ. Contralateral Prophylactic Mastectomy for Women with T4 Locally Advanced Breast Cancer. Ann Surg Oncol. 2016 Oct; 23 (10):3365-70 Epub 2016 June 30
    View PubMed
  90. Murphy BL, Boughey JC, Degnim AC, Hieken TJ, Harmsen WS, Keeney GL, Jakub JW. A Picture is Worth a Thousand Words: Intraoperative Photography as a Quality Metric for Axillary Dissection. Ann Surg Oncol. 2016 Oct; 23 (11):3494-3500 Epub 2016 May 19
    View PubMed
  91. Hieken TJ, Mutter RW, Jakub JW, Boughey JC, Degnim AC, Sukov WR, Childs S, Corbin KS, Furutani KM, Whitaker TJ, Park SS. A Novel Treatment Schedule for Rapid Completion of Surgery and Radiation in Early-Stage Breast Cancer. Ann Surg Oncol. 2016 Oct; 23 (10):3297-303 Epub 2016 June 22
    View PubMed
  92. Landercasper J, Bailey L, Berry TS, Buras RR, Degnim AC, Fayanju OM, Froman J, Gass J, Greenberg C, Mautner SK, Krontiras H, Rao R, Sowden M, Tjoe JA, Wexelman B, Wilke L, Chen SL. Measures of Appropriateness and Value for Breast Surgeons and Their Patients: The American Society of Breast Surgeons Choosing Wisely ((R)) Initiative. Ann Surg Oncol. 2016 Oct; 23 (10):3112-8 Epub 2016 June 22
    View PubMed
  93. Degnim AC, Dupont WD, Radisky DC, Vierkant RA, Frank RD, Frost MH, Winham SJ, Sanders ME, Smith JR, Page DL, Hoskin TL, Vachon CM, Ghosh K, Hieken TJ, Denison LA, Carter JM, Hartmann LC, Visscher DW. Extent of atypical hyperplasia stratifies breast cancer risk in 2 independent cohorts of women. Cancer. 2016 Oct; 122 (19):2971-8 Epub 2016 June 28
    View PubMed
  94. Hieken TJ, Chen J, Hoskin TL, Walther-Antonio M, Johnson S, Ramaker S, Xiao J, Radisky DC, Knutson KL, Kalari KR, Yao JZ, Baddour LM, Chia N, Degnim AC. The Microbiome of Aseptically Collected Human Breast Tissue in Benign and Malignant Disease. Sci Rep. 2016 Aug 3; 6:30751 Epub 2016 Aug 03
    View PubMed
  95. Figueroa JD, Pfeiffer RM, Brinton LA, Palakal MM, Degnim AC, Radisky D, Hartmann LC, Frost MH, Stallings Mann ML, Papathomas D, Gierach GL, Hewitt SM, Duggan MA, Visscher D, Sherman ME. Standardized measures of lobular involution and subsequent breast cancer risk among women with benign breast disease: a nested case-control study. Breast Cancer Res Treat. 2016 Aug; 159 (1):163-72 Epub 2016 Aug 03
    View PubMed
  96. Hoskin TL, Hieken TJ, Degnim AC, Jakub JW, Jacobson SR, Boughey JC. Use of immediate breast reconstruction and choice for contralateral prophylactic mastectomy. Surgery. 2016 Apr; 159 (4):1199-209 Epub 2015 Dec 17
    View PubMed
  97. Meares AL, Frank RD, Degnim AC, Vierkant RA, Frost MH, Hartmann LC, Winham SJ, Visscher DW. Mucocele-like lesions of the breast: a clinical outcome and histologic analysis of 102 cases. Hum Pathol. 2016 Mar; 49:33-8 Epub 2015 Oct 31
    View PubMed
  98. Radisky DC, Visscher DW, Frank RD, Vierkant RA, Winham S, Stallings-Mann M, Hoskin TL, Nassar A, Vachon CM, Denison LA, Hartmann LC, Frost MH, Degnim AC. Natural history of age-related lobular involution and impact on breast cancer risk. Breast Cancer Res Treat. 2016 Feb; 155 (3):423-30 Epub 2016 Feb 04
    View PubMed
  99. Visscher DW, Frost MH, Hartmann LC, Frank RD, Vierkant RA, McCullough AE, Winham SJ, Vachon CM, Ghosh K, Brandt KR, Farrell AM, Tarabishy Y, Hieken TJ, Haddad TC, Kraft RA, Radisky DC, Degnim AC. Clinicopathologic features of breast cancers that develop in women with previous benign breast disease. Cancer. 2016 Feb 1; 122 (3):378-85 Epub 2015 Oct 29
    View PubMed
  100. Abdelsattar JM, Boughey JC, Fahy AS, Jakub JW, Farley DR, Hieken TJ, Degnim AC, Goede W, Mohan AT, Harmsen WS, Niesen AD, Tran NV, Bakri K, Jacobson SR, Lemaine V, Saint-Cyr M. Comparative Study of Liposomal Bupivacaine Versus Paravertebral Block for Pain Control Following Mastectomy with Immediate Tissue Expander Reconstruction. Ann Surg Oncol. 2016 Feb; 23 (2):465-70 Epub 2015 Aug 26
    View PubMed
  101. Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, Vierkant RA, Maloney SD, Pankratz VS, Hillman DW, Suman VJ, Johnson J, Blake C, Tlsty T, Vachon CM, Melton LJ, Visscher DW. Benign breast disease and the risk of breast cancer Obstetrical and Gynecological Survey. 2016; 71: (8)472-3.
  102. Erdahl LM, Boughey JC, Hoskin TL, Degnim AC, Hieken TJ. Contralateral Prophylactic Mastectomy: Factors Predictive of Occult Malignancy or High-Risk Lesion and the Impact of MRI and Genetic Testing. Ann Surg Oncol. 2016 Jan; 23: (1)72-7.
    View PubMed
  103. Reusche R, Winocour S, Degnim A, Lemaine V. Diffuse dermal angiomatosis of the breast: a series of 22 cases from a single institution. Gland Surg. 2015 Dec; 4 (6):554-60
    View PubMed
  104. Hieken TJ, Carter JM, Hawse JR, Hoskin TL, Bois M, Frost M, Hartmann LC, Radisky DC, Visscher DW, Degnim AC. ERbeta expression and breast cancer risk prediction for women with atypias. Cancer Prev Res (Phila). 2015 Nov; 8 (11):1084-92 Epub 2015 Aug 14
    View PubMed
  105. Krajewski AC, Boughey JC, Degnim AC, Jakub JW, Jacobson SR, Hoskin TL, Hieken TJ. Expanded Indications and Improved Outcomes for Nipple-Sparing Mastectomy Over Time. Ann Surg Oncol. 2015 Oct; 22 (10):3317-23 Epub 2015 July 23
    View PubMed
  106. Lemaine V, Hoskin TL, Farley DR, Grant CS, Boughey JC, Torstenson TA, Jacobson SR, Jakub JW, Degnim AC. Introducing the SKIN score: a validated scoring system to assess severity of mastectomy skin flap necrosis. Ann Surg Oncol. 2015 Sep; 22 (9):2925-32 Epub 2015 Jan 30
    View PubMed
  107. Nassar A, Visscher DW, Degnim AC, Frank RD, Vierkant RA, Frost M, Radisky DC, Vachon CM, Kraft RA, Hartmann LC, Ghosh K. Complex fibroadenoma and breast cancer risk: a Mayo Clinic Benign Breast Disease Cohort Study. Breast Cancer Res Treat. 2015 Sep; 153 (2):397-405 Epub 2015 Aug 12
    View PubMed
  108. Degnim AC, Nassar A, Stallings-Mann M, Keith Anderson S, Oberg AL, Vierkant RA, Frank RD, Wang C, Winham SJ, Frost MH, Hartmann LC, Visscher DW, Radisky DC. Gene signature model for breast cancer risk prediction for women with sclerosing adenosis. Breast Cancer Res Treat. 2015 Aug; 152 (3):687-94 Epub 2015 July 23
    View PubMed
  109. Said SM, Visscher DW, Nassar A, Frank RD, Vierkant RA, Frost MH, Ghosh K, Radisky DC, Hartmann LC, Degnim AC. Flat epithelial atypia and risk of breast cancer: A Mayo cohort study. Cancer. 2015 May 15; 121 (10):1548-55 Epub 2015 Jan 13
    View PubMed
  110. Nassar A, Hoskin TL, Stallings-Mann ML, Degnim AC, Radisky DC, Frost MH, Vierkant RA, Hartmann LC, Visscher DW. Ki-67 expression in sclerosing adenosis and adjacent normal breast terminal ductal lobular units: a nested case-control study from the Mayo Benign Breast Disease Cohort. Breast Cancer Res Treat. 2015 May; 151 (1):89-97 Epub 2015 Apr 12
    View PubMed
  111. Pankratz VS, Degnim AC, Frank RD, Frost MH, Visscher DW, Vierkant RA, Hieken TJ, Ghosh K, Tarabishy Y, Vachon CM, Radisky DC, Hartmann LC. Model for individualized prediction of breast cancer risk after a benign breast biopsy. J Clin Oncol. 2015 Mar 10; 33 (8):923-9 Epub 2015 Jan 26
    View PubMed
  112. Boughey JC, Hoskin TL, Hartmann LC, Johnson JL, Jacobson SR, Degnim AC, Frost MH. Impact of reconstruction and reoperation on long-term patient-reported satisfaction after contralateral prophylactic mastectomy. Ann Surg Oncol. 2015 Feb; 22 (2):401-8 Epub 2014 Sept 06
    View PubMed
  113. Mallory MJ, Croghan KA, Sandhu NP, Lemaine V, Degnim AC, Bauer BA, Cha SS, Croghan IT. Acupuncture in the postoperative setting for breast cancer patients: a feasibility study. Am J Chin Med. 2015; 43 (1):45-56
    View PubMed
  114. Hartmann LC, Degnim AC, Santen RJ, Dupont WD, Ghosh K. Atypical hyperplasia of the breast--risk assessment and management options. N Engl J Med. 2015 Jan 1; 372 (1):78-89
    View PubMed
  115. Mitro SD, Ali-Fehmi R, Bandyopadhyay S, Alosh B, Albashiti B, Radisky DC, Frost MH, Degnim AC, Ruterbusch JJ, Cote ML. Clinical characteristics of breast cancers in African-American women with benign breast disease: a comparison to the surveillance, epidemiology, and end results program. Breast J. 2014 Nov; 20(6):571-7.
    View PubMed
  116. Figueroa JD, Pfeiffer RM, Patel DA, Linville L, Brinton LA, Gierach GL, Yang XR, Papathomas D, Visscher D, Mies C, Degnim AC, Anderson WF, Hewitt S, Khodr ZG, Clare SE, Storniolo AM, Sherman ME. Terminal duct lobular unit involution of the normal breast: implications for breast cancer etiology. J Natl Cancer Inst. 2014 Oct; 106 (10) Epub 2014 Oct 01
    View PubMed
  117. Landercasper J, Whitacre E, Degnim AC, Al-Hamadani M. Reasons for re-excision after lumpectomy for breast cancer: insight from the American Society of Breast Surgeons Mastery(sm) database. Ann Surg Oncol. 2014 Oct; 21(10):3185-91.
    View PubMed
  118. Degnim AC, Hoskin TL, Brahmbhatt RD, Warren-Peled A, Loprinzi M, Pavey ES, Boughey JC, Hieken TJ, Jacobson S, Lemaine V, Jakub JW, Irwin C, Foster RD, Sbitany H, Saint-Cyr M, Duralde E, Ramaker S, Chin R, Sieg M, Wildeman M, Scow JS, Patel R, Ballman K, Baddour LM, Esserman LJ. Randomized trial of drain antisepsis after mastectomy and immediate prosthetic breast reconstruction. Ann Surg Oncol. 2014 Oct; 21 (10):3240-8 Epub 2014 Aug 06
    View PubMed
  119. Boughey JC, Hieken TJ, Jakub JW, Degnim AC, Grant CS, Farley DR, Thomsen KM, Osborn JB, Keeney GL, Habermann EB. Impact of analysis of frozen-section margin on reoperation rates in women undergoing lumpectomy for breast cancer: evaluation of the National Surgical Quality Improvement Program data. Surgery. 2014 Jul; 156 (1):190-7 Epub 2014 Mar 18
    View PubMed
  120. Boughey JC, Hoskin TL, Cheville AL, Miller J, Loprinzi MD, Thomsen KM, Maloney S, Baddour LM, Degnim AC. Risk factors associated with breast lymphedema. Ann Surg Oncol. 2014 Apr; 21 (4):1202-8 Epub 2013 Dec 12
    View PubMed
  121. Degnim AC, Brahmbhatt RD, Radisky DC, Hoskin TL, Stallings-Mann M, Laudenschlager M, Mansfield A, Frost MH, Murphy L, Knutson K, Visscher DW. Immune cell quantitation in normal breast tissue lobules with and without lobulitis. Breast Cancer Res Treat. 2014 Apr; 144 (3):539-49 Epub 2014 Mar 05
    View PubMed
  122. Lemaine V, Hoskin TL, Boughey JC, Farley DR, Grant CS, Jacobson SR, Jakub JW, Torstenson TT, Reusche RD, Degnim AC. Abstract 99: reducing unplanned reoperations for mastectomy skin flap necrosis - a multidisciplinary approach. Plast Reconstr Surg. 2014 Mar; 133 (3 Suppl):112
    View PubMed
  123. Hartmann LC, Radisky DC, Frost MH, Santen RJ, Vierkant RA, Benetti LL, Tarabishy Y, Ghosh K, Visscher DW, Degnim AC. Understanding the premalignant potential of atypical hyperplasia through its natural history: a longitudinal cohort study. Cancer Prev Res (Phila). 2014 Feb; 7 (2):211-7 Epub 2014 Jan 30
    View PubMed
  124. Visscher DW, Nassar A, Degnim AC, Frost MH, Vierkant RA, Frank RD, Tarabishy Y, Radisky DC, Hartmann LC. Sclerosing adenosis and risk of breast cancer. Breast Cancer Res Treat. 2014 Feb; 144 (1):205-12 Epub 2014 Feb 08
    View PubMed
  125. D'Assoro AB, Liu T, Quatraro C, Amato A, Opyrchal M, Leontovich A, Ikeda Y, Ohmine S, Lingle W, Suman V, Ecsedy J, Iankov I, Di Leonardo A, Ayers-Inglers J, Degnim A, Billadeau D, McCubrey J, Ingle J, Salisbury JL, Galanis E. The mitotic kinase Aurora--a promotes distant metastases by inducing epithelial-to-mesenchymal transition in ERalpha(+) breast cancer cells. Oncogene. 2014 Jan 30; 33 (5):599-610 Epub 2013 Jan 21
    View PubMed
  126. Opyrchal M, Salisbury JL, Zhang S, McCubrey J, Hawse J, Goetz MP, Lomberk GA, Haddad T, Degnim A, Lange C, Ingle JN, Galanis E, D'Assoro AB. Aurora-A mitotic kinase induces endocrine resistance through down-regulation of ERalpha expression in initially ERalpha+ breast cancer cells. PLoS One. 2014; 9 (5):e96995 Epub 2014 May 09
    View PubMed
  127. Degnim AC, Scow JS, Hoskin TL, Miller JP, Loprinzi M, Boughey JC, Jakub JW, Throckmorton A, Patel R, Baddour LM. Randomized controlled trial to reduce bacterial colonization of surgical drains after breast and axillary operations. Ann Surg. 2013 Aug; 258 (2):240-7
    View PubMed
  128. Degnim AC, King TA. Surgical management of high-risk breast lesions. Surg Clin North Am. 2013 Apr; 93 (2):329-40 Epub 2013 Feb 08
    View PubMed
  129. Jones KN, Guimaraes LS, Reynolds CA, Ghosh K, Degnim AC, Glazebrook KN. Invasive micropapillary carcinoma of the breast: imaging features with clinical and pathologic correlation. AJR Am J Roentgenol. 2013 Mar; 200 (3):689-95
    View PubMed
  130. Warren R, Degnim AC. Uncommon benign breast abnormalities in adolescents. Semin Plast Surg. 2013 Feb; 27 (1):26-8
    View PubMed
  131. Yau C, Sninsky J, Kwok S, Wang A, Degnim A, Ingle JN, Gillett C, Tutt A, Waldman F, Moore D, Esserman L, Benz CC. An optimized five-gene multi-platform predictor of hormone receptor negative and triple negative breast cancer metastatic risk. Breast Cancer Res. 2013; 15(5):R103.
    View PubMed
  132. Degnim AC, Throckmorton AD, Boostrom SY, Boughey JC, Holifield A, Baddour LM, Hoskin TL. Surgical site infection after breast surgery: impact of 2010 CDC reporting guidelines. Ann Surg Oncol. 2012 Dec; 19 (13):4099-103 Epub 2012 June 26
    View PubMed
  133. Shah-Khan MG, Lovely J, Degnim AC. Safety of methylene blue dye for lymphatic mapping in patients taking selective serotonin reuptake inhibitors. Am J Surg. 2012 Nov; 204 (5):798-9 Epub 2012 May 09
    View PubMed
  134. Brahmbhatt RD, Huebner M, Scow JS, Harmsen WS, Boughey JC, Harris AM, Goede D, Jakub JW, Hieken TJ, Degnim AC. National practice patterns in preoperative and postoperative antibiotic prophylaxis in breast procedures requiring drains: survey of the American Society of Breast Surgeons. Ann Surg Oncol. 2012 Oct; 19 (10):3205-11 Epub 2012 July 06
    View PubMed
  135. Lovely JK, Nehring SA, Boughey JC, Degnim AC, Donthi R, Harmsen WS, Jakub JW. Balancing venous thromboembolism and hematoma after breast surgery. Ann Surg Oncol. 2012 Oct; 19 (10):3230-5 Epub 2012 July 21
    View PubMed
  136. Ansari B, Boughey JC, Adamczyk DL, Degnim AC, Jakub JW, Morton MJ. Should axillary ultrasound be used in patients with a preoperative diagnosis of ductal carcinoma in situ? Am J Surg. 2012 Sep; 204: (3)290-3.
    View PubMed
  137. Degnim AC, Miller J, Hoskin TL, Boughey JC, Loprinzi M, Thomsen K, Maloney S, Baddour LM, Cheville AL. A prospective study of breast lymphedema: frequency, symptoms, and quality of life. Breast Cancer Res Treat. 2012 Aug; 134 (3):915-22 Epub 2012 Mar 14
    View PubMed
  138. Leontovich AA, Zhang S, Quatraro C, Iankov I, Veroux PF, Gambino MW, Degnim A, McCubrey J, Ingle J, Galanis E, D'Assoro AB. Raf-1 oncogenic signaling is linked to activation of mesenchymal to epithelial transition pathway in metastatic breast cancer cells. Int J Oncol. 2012 Jun; 40 (6):1858-64 Epub 2012 Mar 19
    View PubMed
  139. Degnim AC, Visscher DW, Hoskin TL, Frost MH, Vierkant RA, Vachon CM, Shane Pankratz V, Radisky DC, Hartmann LC. Histologic findings in normal breast tissues: comparison to reduction mammaplasty and benign breast disease tissues. Breast Cancer Res Treat. 2012 May; 133 (1):169-77 Epub 2011 Sept 01
    View PubMed
  140. Drackley NL, Degnim AC, Jakub JW, Cutshall SM, Thomley BS, Brodt JK, Vanderlei LK, Case JK, Bungum LD, Cha SS, Bauer BA, Boughey JC. Effect of massage therapy for postsurgical mastectomy recipients. Clin J Oncol Nurs. 2012 Apr; 16 (2):121-4
    View PubMed
  141. Miles RC, Gullerud RE, Lohse CM, Jakub JW, Degnim AC, Boughey JC. Local recurrence after breast-conserving surgery: multivariable analysis of risk factors and the impact of young age. Ann Surg Oncol. 2012 Apr; 19 (4):1153-9 Epub 2011 Oct 12
    View PubMed
  142. Fuehrer N, Hartmann L, Degnim A, Allers T, Vierkant R, Frost M, Visscher D. Atypical apocrine adenosis of the breast: long-term follow-up in 37 patients. Arch Pathol Lab Med. 2012 Feb; 136 (2):179-82
    View PubMed
  143. Diaz R, Degnim AC, Boughey JC, Nassar A, Jakub JW. A positive intramammary lymph node does not mandate a complete axillary node dissection. Am J Surg. 2012 Feb; 203(2):151-5. Epub 2011 Jul 23.
    View PubMed
  144. Mittendorf EA, Hunt KK, Boughey JC, Bassett R, Degnim AC, Harrell R, Yi M, Meric-Bernstam F, Ross MI, Babiera GV, Kuerer HM, Hwang RF. Incorporation of sentinel lymph node metastasis size into a nomogram predicting nonsentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node. Ann Surg. 2012 Jan; 255(1):109-15.
    View PubMed
  145. Frost MH, Hoskin TL, Hartmann LC, Degnim AC, Johnson JL, Boughey JC. Contralateral prophylactic mastectomy: long-term consistency of satisfaction and adverse effects and the significance of informed decision-making, quality of life, and personality traits. Ann Surg Oncol. 2011 Oct; 18 (11):3110-6 Epub 2011 Sept 27
    View PubMed
  146. Reynolds C, Davidson JA, Lindor NM, Glazebrook KN, Jakub JW, Degnim AC, Sandhu NP, Walsh MF, Hartmann LC, Boughey JC. Prophylactic and therapeutic mastectomy in BRCA mutation carriers: can the nipple be preserved? Ann Surg Oncol. 2011 Oct; 18(11):3102-9. Epub 2011 Sep 27.
    View PubMed
  147. Ansari B, Morton MJ, Adamczyk DL, Jones KN, Brodt JK, Degnim AC, Jakub JW, Lohse CM, Boughey JC. Distance of breast cancer from the skin and nipple impacts axillary nodal metastases. Ann Surg Oncol. 2011 Oct; 18 (11):3174-80 Epub 2011 Aug 23
    View PubMed
  148. Osborn JB, Keeney GL, Jakub JW, Degnim AC, Boughey JC. Cost-effectiveness analysis of routine frozen-section analysis of breast margins compared with reoperation for positive margins. Ann Surg Oncol. 2011 Oct; 18(11):3204-9. Epub 2011 Aug 23.
    View PubMed
  149. Zendejas B, Moriarty JP, O'Byrne J, Degnim AC, Farley DR, Boughey JC. Cost-effectiveness of contralateral prophylactic mastectomy versus routine surveillance in patients with unilateral breast cancer. J Clin Oncol. 2011 Aug 1; 29 (22):2993-3000 Epub 2011 June 20
    View PubMed
  150. Sandhu NP, Long HJ, Johnson KJ, Degnim AC. An unusual presentation of breast cancer in a very young woman. BMJ Case Rep. 2011 Mar 15; 2011
    View PubMed
  151. Barr FE, Degnim AC, Hartmann LC, Radisky DC, Boughey JC, Anderson SS, Vierkant RA, Frost MH, Visscher DW, Reynolds C. Estrogen receptor expression in atypical hyperplasia: lack of association with breast cancer. Cancer Prev Res (Phila). 2011 Mar; 4(3):435-44. Epub 2011 Jan 05.
    View PubMed
  152. Sandhu NP, Zakaria S, Degnim AC, Boughey JC. Dermatomyositis presenting as a paraneoplastic syndrome due to underlying breast cancer. BMJ Case Rep. 2011 Feb 2; 2011 Epub 2011 Feb 02
    View PubMed
  153. Wahner-Roedler DL, Hruska CB, O'Connor MK, Phillips SW, Whaley DH, Johnson RE, Degnim AC, Boughey JC, Rhodes DJ. Molecular breast imaging for women presenting with a history of non-reproducible bloody nipple discharge and negative findings on routine imaging studies: A pilot study. Journal of Surgical Radiology. 2011; 2(1):92-9.
  154. Pruthi S, Haakenson C, Brost BC, Bryant K, Reid JM, Singh R, Netzel B, Boughey JC, Degnim AC. Pharmacokinetics of methylene blue dye for lymphatic mapping in breast cancer-implications for use in pregnancy. Am J Surg. 2011 Jan; 201(1):70-5.
    View PubMed
  155. Jakub JW, Bryant K, Huebner M, Hoskin T, Boughey JC, Reynolds C, Degnim AC. The number of axillary lymph nodes involved with metastatic breast cancer does not affect outcome as long as all disease is confined to the sentinel lymph nodes. Ann Surg Oncol. 2011 Jan; 18(1):86-93. Epub 2010 Jul 01.
    View PubMed
  156. Cichon MA, Degnim AC, Visscher DW, Radisky DC. Microenvironmental influences that drive progression from benign breast disease to invasive breast cancer. J Mammary Gland Biol Neoplasia. 2010 Dec; 15 (4):389-97 Epub 2010 Dec 16
    View PubMed
  157. Degnim AC, Frost MH, Radisky DC, Anderson SS, Vierkant RA, Boughey JC, Pankratz VS, Ghosh K, Hartmann LC, Visscher DW. Pseudoangiomatous stromal hyperplasia and breast cancer risk. Ann Surg Oncol. 2010 Dec; 17 (12):3269-77 Epub 2010 June 22
    View PubMed
  158. Misselt PN, Glazebrook KN, Reynolds C, Degnim AC, Morton MJ. Predictive value of sonographic features of extranodal extension in axillary lymph nodes. J Ultrasound Med. 2010 Dec; 29 (12):1705-9
    View PubMed
  159. Nassar A, Sookhan N, Santisteban M, Bryant SC, Boughey JC, Giorgadze T, Degnim A. Diagnostic utility of snail in metaplastic breast carcinoma. Diagn Pathol. 2010 Nov 26; 5:76
    View PubMed
  160. Zendejas B, Hoskin TL, Degnim AC, Reynolds CA, Farley DR, Boughey JC. Predicting four or more metastatic axillary lymph nodes in patients with sentinel node-positive breast cancer: assessment of existent risk scores. Ann Surg Oncol. 2010 Nov; 17 (11):2884-91 Epub 2010 Apr 29
    View PubMed
  161. Boughey JC, Hoskin TL, Degnim AC, Sellers TA, Johnson JL, Kasner MJ, Hartmann LC, Frost MH. Contralateral prophylactic mastectomy is associated with a survival advantage in high-risk women with a personal history of breast cancer. Ann Surg Oncol. 2010 Oct; 17 (10):2702-9 Epub 2010 Sept 19
    View PubMed
  162. Fedko MG, Scow JS, Shah SS, Reynolds C, Degnim AC, Jakub JW, Boughey JC. Pure tubular carcinoma and axillary nodal metastases. Ann Surg Oncol. 2010 Oct; 17 Suppl 3:338-42 Epub 2010 Sept 19
    View PubMed
  163. Degnim AC, Zakaria S, Boughey JC, Sookhan N, Reynolds C, Donohue JH, Farley DR, Grant CS, Hoskin T. Axillary recurrence in breast cancer patients with isolated tumor cells in the sentinel lymph node [AJCC N0(i+)]. Ann Surg Oncol. 2010 Oct; 17(10):2685-9.
    View PubMed
  164. Pockaj BA, Wasif N, Dueck AC, Wigle DA, Boughey JC, Degnim AC, Gray RJ, McLaughlin SA, Northfelt DW, Sticca RP, Jakub JW, Perez EA. Metastasectomy and surgical resection of the primary tumor in patients with stage IV breast cancer: time for a second look? Ann Surg Oncol. 2010 Sep; 17 (9):2419-26 Epub 2010 Mar 16
    View PubMed
  165. Throckmorton AD, Baddour LM, Hoskin TL, Boughey JC, Degnim AC. Microbiology of surgical site infections complicating breast surgery. Surg Infect (Larchmt). 2010 Aug; 11(4):355-9.
    View PubMed
  166. Boughey JC, Hartmann LC, Anderson SS, Degnim AC, Vierkant RA, Reynolds CA, Frost MH, Pankratz VS. Evaluation of the Tyrer-Cuzick (International Breast Cancer Intervention Study) model for breast cancer risk prediction in women with atypical hyperplasia. J Clin Oncol. 2010 Aug 1; 28 (22):3591-6 Epub 2010 July 06
    View PubMed
  167. Boughey JC, Donohue JH, Jakub JW, Lohse CM, Degnim AC. Number of lymph nodes identified at axillary dissection: effect of neoadjuvant chemotherapy and other factors. Cancer. 2010 Jul 15; 116 (14):3322-9
    View PubMed
  168. Santisteban M, Reynolds C, Barr Fritcher EG, Frost MH, Vierkant RA, Anderson SS, Degnim AC, Visscher DW, Pankratz VS, Hartmann LC. Ki67: a time-varying biomarker of risk of breast cancer in atypical hyperplasia. Breast Cancer Res Treat. 2010 Jun; 121(2):431-7. Epub 2009 Sep 23.
    View PubMed
  169. Jakub JW, Gray RJ, Degnim AC, Boughey JC, Gardner M, Cox CE. Current status of radioactive seed for localization of non palpable breast lesions. Am J Surg. 2010 Apr; 199 (4):522-8 Epub 2009 Dec 02
    View PubMed
  170. Boughey JC, Moriarty JP, Degnim AC, Gregg MS, Egginton JS, Long KH. Cost modeling of preoperative axillary ultrasound and fine-needle aspiration to guide surgery for invasive breast cancer. Ann Surg Oncol. 2010 Apr; 17 (4):953-8 Epub 2010 Feb 02
    View PubMed
  171. Scow JS, Reynolds CA, Degnim AC, Petersen IA, Jakub JW, Boughey JC. Primary and secondary angiosarcoma of the breast: the Mayo Clinic experience. J Surg Oncol. 2010 Apr 1; 101 (5):401-7
    View PubMed
  172. Mathis KL, Hoskin TL, Boughey JC, Crownhart BS, Brandt KR, Vachon CM, Grant CS, Degnim AC. Palpable presentation of breast cancer persists in the era of screening mammography. J Am Coll Surg. 2010 Mar; 210: (3)314-8.
    View PubMed
  173. Neal L, Boughey J, Degnim A, Wilshusen L, Locke G, Pruthi S. Improving patient satisfaction: an opportunity for integrated group practice. Group Practice Journal. 2010; 60(2):22-7.
  174. Grotz TE, Tortorelli CL, Degnim AC, Boughey JC, Whaley DH, Jakub JW. The use of radioactive seed localization for non-palpable non-breast lesions. Journal of Surgical Radiology. 2010; 1(2).
  175. McKian KP, Reynolds CA, Visscher DW, Nassar A, Radisky DC, Vierkant RA, Degnim AC, Boughey JC, Ghosh K, Anderson SS, Minot D, Caudill JL, Vachon CM, Frost MH, Pankratz VS, Hartmann LC. Novel breast tissue feature strongly associated with risk of breast cancer. J Clin Oncol. 2009 Dec 10; 27 (35):5893-8 Epub 2009 Oct 05
    View PubMed
  176. Scow JS, Degnim AC, Hoskin TL, Reynolds C, Boughey JC. Simple prediction models for breast cancer patients with solitary positive sentinel nodes--are they valid? Breast J. 2009 Nov-Dec; 15(6):610-4. Epub 2009 Oct 12.
    View PubMed
  177. Throckmorton AD, Hoskin T, Boostrom SY, Boughey JC, Holifield AC, Stobbs MM, Baddour LM, Degnim AC. Complications associated with postoperative antibiotic prophylaxis after breast surgery. Am J Surg. 2009 Oct; 198(4):553-6.
    View PubMed
  178. Scow JS, Degnim AC, Hoskin TL, Reynolds C, Boughey JC. Assessment of the performance of the Stanford Online Calculator for the prediction of nonsentinel lymph node metastasis in sentinel lymph node-positive breast cancer patients. Cancer. 2009 Sep 15; 115 (18):4064-70
    View PubMed
  179. Katipamula R, Degnim AC, Hoskin T, Boughey JC, Loprinzi C, Grant CS, Brandt KR, Pruthi S, Chute CG, Olson JE, Couch FJ, Ingle JN, Goetz MP. Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging. J Clin Oncol. 2009 Sep 1; 27 (25):4082-8 Epub 2009 July 27
    View PubMed
  180. Degnim AC, Hartmann LC. Refining risk assessment in women with atypical hyperplasia. Curr Breast Ca Rep. 2009 Sep; 1(3):167-74.
  181. Throckmorton AD, Boughey JC, Boostrom SY, Holifield AC, Stobbs MM, Hoskin T, Baddour LM, Degnim AC. Postoperative prophylactic antibiotics and surgical site infection rates in breast surgery patients. Ann Surg Oncol. 2009 Sep; 16 (9):2464-9 Epub 2009 June 09
    View PubMed
  182. Vierkant RA, Hartmann LC, Pankratz VS, Anderson SS, Radisky D, Frost MH, Vachon CM, Ghosh K, Distad TJ, Degnim AC, Reynolds CA. Lobular involution: localized phenomenon or field effect? Breast Cancer Res Treat. 2009 Sep; 117 (1):193-6 Epub 2008 July 01
    View PubMed
  183. Pruthi S, Degnim AC, Bauer BA, DePompolo RW, Nayar V. Value of massage therapy for patients in a breast clinic. Clin J Oncol Nurs. 2009 Aug; 13(4):422-5.
    View PubMed
  184. Pockaj BA, Degnim AC, Boughey JC, Gray RJ, McLaughlin SA, Dueck AC, Perez EA, Halyard MY, Frost MH, Cheville AL, Sloan JA. Quality of life after breast cancer surgery: What have we learned and where should we go next? J Surg Oncol. 2009 Jun 1; 99 (7):447-55
    View PubMed
  185. Vijan SS, Hamilton S, Chen B, Reynolds C, Boughey JC, Degnim AC. Intramammary lymph nodes: patterns of discovery and clinical significance. Surgery. 2009 May; 145(5):495-9. Epub 2009 Mar 29.
    View PubMed
  186. Zakaria S, Brandt KR, Degnim AC, Thomsen KM. Patients' perceptions of breast MRI: a single-center study. AJR Am J Roentgenol. 2009 Apr; 192 (4):1149-54
    View PubMed
  187. Boostrom SY, Throckmorton AD, Boughey JC, Holifield AC, Zakaria S, Hoskin TL, Degnim AC. Incidence of clinically significant seroma after breast and axillary surgery. J Am Coll Surg. 2009 Jan; 208(1):148-50. Epub 2008 Oct 02.
    View PubMed
  188. Pankratz VS, Hartmann LC, Degnim AC, Vierkant RA, Ghosh K, Vachon CM, Frost MH, Maloney SD, Reynolds C, Boughey JC. Assessment of the accuracy of the Gail model in women with atypical hyperplasia. J Clin Oncol. 2008 Nov 20; 26 (33):5374-9 Epub 2008 Oct 14
    View PubMed
  189. Hruska CB, Boughey JC, Phillips SW, Rhodes DJ, Wahner-Roedler DL, Whaley DH, Degnim AC, O'Connor MK. Scientific Impact Recognition Award: Molecular breast imaging: a review of the Mayo Clinic experience. Am J Surg. 2008 Oct; 196 (4):470-6 Epub 2008 Aug 23
    View PubMed
  190. Sookhan N, Boughey JC, Walsh MF, Degnim AC. Nipple-sparing mastectomy--initial experience at a tertiary center. Am J Surg. 2008 Oct; 196(4):575-7.
    View PubMed
  191. Throckmorton AD, Askegard-Giesmann J, Hoskin TL, Bjarnason H, Donohue JH, Boughey JC, Degnim AC. Sclerotherapy for the treatment of postmastectomy seroma. Am J Surg. 2008 Oct; 196 (4):541-4
    View PubMed
  192. Zakaria S, Hoskin TL, Degnim AC. Safety and technical success of methylene blue dye for lymphatic mapping in breast cancer. Am J Surg. 2008 Aug; 196(2):228-33.
    View PubMed
  193. Zakaria S, Pantvaidya G, Reynolds CA, Grant CS, Sterioff S, Donohue JH, Farley DR, Hoskin TL, Degnim AC. Sentinel node positive breast cancer patients who do not undergo axillary dissection: are they different? Surgery. 2008 May; 143(5):641-7. Epub 2008 Feb 13.
    View PubMed
  194. Degnim AC, Boughey JC, Sookhan N. Partial breast irradiation: rating today's evidence. Contemp Surg. 2008 May; 64(5):220-225.
  195. Truty MJ, Stulak JM, Utter PA, Solberg JJ, Degnim AC. Appendicitis after appendectomy. Arch Surg. 2008 Apr; 143 (4):413-5
    View PubMed
  196. Hughes JH, Mason MC, Gray RJ, McLaughlin SA, Degnim AC, Fulmer JT, Pockaj BA, Karstaedt PJ, Roarke MC. A multi-site validation trial of radioactive seed localization as an alternative to wire localization. Breast J. 2008 Mar-Apr; 14 (2):153-7 Epub 2008 Jan 31
    View PubMed
  197. Berg JC, Visscher DW, Vierkant RA, Pankratz VS, Maloney SD, Lewis JT, Frost MH, Ghosh K, Degnim AC, Brandt KR, Vachon CM, Reynolds CA, Hartmann LC. Breast cancer risk in women with radial scars in benign breast biopsies. Breast Cancer Res Treat. 2008 Mar; 108 (2):167-74 Epub 2007 May 22
    View PubMed
  198. Zakaria S, Degnim AC, Kleer CG, Diehl KA, Cimmino VM, Chang AE, Newman LA, Sabel MS. Sentinel lymph node biopsy for breast cancer: how many nodes are enough? J Surg Oncol. 2007 Dec 1; 96 (7):554-9
    View PubMed
  199. Gray RJ, Mulheron B, Pockaj BA, Degnim A, Smith SL. The optimal management of the axillae of patients with microinvasive breast cancer in the sentinel lymph node era. Am J Surg. 2007 Dec; 194 (6):845-8; discussion 848-9
    View PubMed
  200. Giuliano AE, Boolbol S, Degnim A, Kuerer H, Leitch AM, Morrow M. Society of surgical oncology: position statement on prophylactic mastectomy. approved by the society of surgical oncology executive council, march 2007. Ann Surg Oncol. 2007 Sep; 14(9):2425-7. Epub 2007 Jun 28.
    View PubMed
  201. Pruthi S, Boughey JC, Brandt KR, Degnim AC, Dy GK, Goetz MP, Perez EA, Reynolds CA, Schomberg PJ, Ingle JN. A multidisciplinary approach to the management of breast cancer, part 2: therapeutic considerations. Mayo Clin Proc. 2007 Sep; 82 (9):1131-40
    View PubMed
  202. Pruthi S, Brandt KR, Degnim AC, Goetz MP, Perez EA, Reynolds CA, Schomberg PJ, Dy GK, Ingle JN. A multidisciplinary approach to the management of breast cancer, part 1: prevention and diagnosis. Mayo Clin Proc. 2007 Aug; 82(8):999-1012.
    View PubMed
  203. Degnim AC, Visscher DW, Berman HK, Frost MH, Sellers TA, Vierkant RA, Maloney SD, Pankratz VS, de Groen PC, Lingle WL, Ghosh K, Penheiter L, Tlsty T, Melton LJ 3rd, Reynolds CA, Hartmann LC. Stratification of breast cancer risk in women with atypia: a Mayo cohort study. J Clin Oncol. 2007 Jul 1; 25(19):2671-7. Epub 2007 Jun 11.
    View PubMed
  204. Zakaria S, Johnson R, Pockaj BA, Degnim AC. Breast cancer presenting as unilateral arm edema. J Gen Intern Med. 2007 May; 22 (5):675-6
    View PubMed
  205. Zakaria S, Pantvaidya G, Ghosh K, Degnim AC. Paget's disease of the breast: accuracy of preoperative assessment. Breast Cancer Res Treat. 2007 Apr; 102 (2):137-42 Epub 2006 Sept 21
    View PubMed
  206. Zakaria S, Degnim AC. Prophylactic mastectomy. Surg Clin North Am. 2007 Apr; 87(2):317-31, viii.
    View PubMed
  207. Milanese TR, Hartmann LC, Sellers TA, Frost MH, Vierkant RA, Maloney SD, Pankratz VS, Degnim AC, Vachon CM, Reynolds CA, Thompson RA, Melton LJ, Goode EL, Visscher DW. Age-related lobular involution and risk of breast cancer. J Natl Cancer Inst. 2006 Nov 15; 98 (22):1600-7
    View PubMed
  208. Li S, Grant CS, Degnim A, Donohue J. Surgical management of recurrent subareolar breast abscesses: Mayo Clinic experience. Am J Surg. 2006 Oct; 192 (4):528-9
    View PubMed
  209. Smoot RL, Koch CA, Degnim AC, Sterioff S, Donohue JH, Grant CS, Barnes SA, Gullerud RE, Hobday TJ, Farley DR. A single-center experience with inflammatory breast cancer, 1985-2003. Arch Surg. 2006 Jun; 141(6):567-72; discussion 572-3.
    View PubMed
  210. Rivers AK, Griffith KA, Hunt KK, Degnim AC, Sabel MS, Diehl KM, Cimmino VM, Chang AE, Lucas PC, Newman LA. Clinicopathologic features associated with having four or more metastatic axillary nodes in breast cancer patients with a positive sentinel lymph node. Ann Surg Oncol. 2006 Jan; 13(1):36-44. Epub 2006 Jan 01.
    View PubMed
  211. Burkle CM, Jankowski CJ, Torsher LC, Rho EH, Degnim AC. BIS monitor findings during self-hypnosis. J Clin Monit Comput. 2005 Dec; 19 (6):391-3 Epub 2006 Jan 25
    View PubMed
  212. Degnim AC, Reynolds C, Pantvaidya G, Zakaria S, Hoskin T, Barnes S, Roberts MV, Lucas PC, Oh K, Koker M, Sabel MS, Newman LA. Nonsentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram. Am J Surg. 2005 Oct; 190 (4):543-50
    View PubMed
  213. Walsh MF, Degnim AC, Luong JA. Vertical mastectomy -- a better choice for reconstruction. Plast Reconstr Surg. 2005 Sept; 116(3):236-237.
  214. Degnim AC, Oh K, Cimmino VM, Diehl KM, Chang AE, Newman LA, Sabel MS. Is blue dye indicated for sentinel lymph node biopsy in breast cancer patients with a positive lymphoscintigram? Ann Surg Oncol. 2005 Sep; 12(9):712-7.
    View PubMed
  215. Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, Vierkant RA, Maloney SD, Pankratz VS, Hillman DW, Suman VJ, Johnson J, Blake C, Tlsty T, Vachon CM, Melton LJ 3rd, Visscher DW. Benign breast disease and the risk of breast cancer. N Engl J Med. 2005 Jul 21; 353 (3):229-37
    View PubMed
  216. Cimmino VM, Degnim AC, Sabel MS, Diehl KM, Newman LA, Chang AE. Efficacy of sentinel lymph node biopsy in male breast cancer. Journal of Surgical Oncology. 2004; 86:74-77.
    View PubMed
  217. Sabel MS, Degnim AC, Wilkins EG, Diehl KM, Cimmino VM, Chang, AE, Newman LA. Mastectomy and concomitant sentinel lymph node biopsy for invasive breast cancer. American Journal of Surgery. 2004; 187:673-678.
    View PubMed
  218. Degnim AC, Griffith KA, Sabel MS, Hayes DF, Cimmino VM, Diehl KM, Lucas PC, Snyder ML, Chang AE, Newman LA. Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma patients - A metaanalysis. Cancer. 2003 Dec 1; 98(11):2307-15.
    View PubMed
  219. Degnim AC, Morrow SE, Ku J, Zar HA, Nakayama DK. Nitric oxide inhibits peroxide-mediated endothelial toxicity. J Surg Res. 1998;75:127-34.
    View PubMed
  220. Prus KL, Heidenreich AC, Zimmerman TP. Transport of the anti-varicella-zoster virus agent 6-methoxypurine arabinoside and its 2'-O-valerate prodrug in human erythrocytes. Antimicrob Agents Chemo. 1992 Feb; 36(32):283-6.